Lyka Labs secures Indian patent for Pregabalin Gel 8% - Indian Pharma Post
4 weeks ago • Google News
Lyka Labs Limited (LYKALABS)
NSEINR 110.34-0.31%
Price Chart
Key Statistics
Market Cap
INR 3.95B
P/E Ratio
96.79
Revenue (TTM)
INR 1.28B
Volume
63.43K
52W High
INR 176.59
52W Low
INR 96.80
Dividend Yield
0.00%
Beta
0.80
Technicals
50-Day MA
107.4982
200-Day MA
135.7294
52 Week High
176.59
52 Week Low
96.8
About LYKALABS
Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India. The com.
Employees
423
Headquarters
Mumbai, India
CEO
Mr. Kunal Narendra Gandhi
Latest News
Lyka Labs Reports Strong Sales Growth Amid Financial Stability Concerns - MarketsMojo
2025-03-03 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg